We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

System for Advanced Parallel Cellular Analysis

By Biotechdaily staff writers
Posted on 09 Oct 2003
A new open technology platform enables researchers to run multiple cell types and markers simultaneously in a single assay well.

The system, called CellCard, together with CellPlex assays allow scientists to generate comprehensive biologic information needed for key decisions much earlier in the drug discovery process. By facilitating parallel screening of multiple cell types and parameters with a diversity of assays, researchers can acquire highly sought-after information in less time than otherwise possible. Cells are grown on CellCards, imaged, and analyzed using the complete turnkey solution developed by Vitra Bioscience (Mountain View, CA, USA).

"By providing researchers with a tool to analyze multiple cell types simultaneously, uniquely inclusive and robust information is obtained earlier and with considerably less effort,” noted Andrew Whiteley, president and CEO of Vitra Bioscience. "This will unequivocally expedite the process of identifying promising clinical compounds.”




Related Links:
Vitra Bioscience

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay

Latest BioResearch News

Genetic Study Links Inherited Blindness to Gene Tied to Rare Metabolic Disorder
09 Oct 2003  |   BioResearch

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
09 Oct 2003  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
09 Oct 2003  |   BioResearch